ESC Premium Access

Target populations and treatment cost for bempedoic acid and PCSK9 inhibitors: a simulation study in a contemporary CAD cohort

Congress Session

About the speaker

Mr Christopher Blaum

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
0 follower

4 more presentations in this session

Impact of ACLY on type 2 diabetes in UK Biobank: A Mendelian randomisation study

Speaker: Doctor A. Stiby (Oxford, GB)


Lipid testing trends before and after hospitalization for myocardial infarction among adults in the U.S., 2008-2019

Speaker: Ms C. Wiener (Durham, US)


The prevalence of statin intolerance worldwide: a systematic review and meta-analysis with 4,143,517 patients

Speaker: Doctor I. Bytyci (Pristina, XK)


Acute arterial events across all vascular territories in the FOURIER trial

Speaker: Doctor K. Oyama (Boston, US)


Access the full session

Highlights from the Young on cutting edge therapy for lowering lipids

Speakers: Mr C. Blaum, Doctor A. Stiby, Ms C. Wiener, Doctor I. Bytyci, Doctor K. Oyama

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Lipoprotein(a): an emerging lipid risk factor – discussion.

27 August 2021

ESC Premium Access

Future treatments for lipoprotein(a).

27 August 2021

ESC Premium Access

Current treatment for elevated lipoprotein(a).

27 August 2021

This platform is supported by

logo Novo Nordisk